Jane Street’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Jane Street’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,700	Closed	-$5K	–	4835
2015 Q3	$5K	Sell	10,700 -3,179	-23%	-$1.82K	﹤0.01%	3488
2015 Q2	$7K	Sell	13,879 -2,800	-17%	-$1.9K	﹤0.01%	3569
2015 Q1	$12K	Buy	+16,679	New	+$10.7K	﹤0.01%	3062
2014 Q4	–	Sell	-62,527	Closed	-$36K	–	3430
2014 Q3	$36K	Buy	62,527 +24,051	+63%	+$30.5K	﹤0.01%	2444
2014 Q2	$49K	Buy	38,476 +15,779	+70%	+$22.6K	﹤0.01%	2430
2014 Q1	$41K	Buy	+22,697	New	+$38.3K	﹤0.01%	2597

Other funds holding ONCY

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

KWMG

King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return

Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Jane Street's ONCY Position: Q4 2015 in Review

Jane Street sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 10,700 shares — an estimated $5K sold.

Jane Street first reported a position in ONCY in Q1 2014 and held it in 6 quarters. The position peaked at $49K in Q2 2014. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

Jane Street reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
Jane Street sold 10,700 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $5K.
Jane Street first reported a position in ONCOLYTICS BIOTECH INC in Q1 2014 and held it in 6 quarters.
Jane Street's ONCOLYTICS BIOTECH INC position peaked at $49K in Q2 2014.
7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Jane Street's 13F filing for Q4 2015, filed 16 Feb 2016.